Radiation therapy for malignant melanoma

Matthew Ballo, K. Kian Ang

Research output: Contribution to journalReview article

60 Citations (Scopus)

Abstract

Although surgery remains the primary treatment for patients with localized melanoma, available data indicate that there is a need for improved local-regional control in situations where complete surgical resection may be difficult or when high-risk features are noted pathologically. Retrospective and phase II prospective studies have revealed that elective/adjuvant radiotherapy can significantly improve the local-regional control rate in these clinical settings. The impact of elective/adjuvant radiotherapy on the incidence of distant metastasis and overall survival has yet to be determined, however. Additionally, there remains a role for radiotherapy as a primary treatment alternative for elderly patients with large facial lentigo maligna melanoma. The optimal radiation fractionation schedule remains controversial. The hypofactionated regimen is well tolerated, has resulted in improved local-regional control as compared with historical surgical results, and is convenient for a group of patients in whom survival expectations are low. Significant improvements in outcome will require commensurate improvements in systemic disease control. The importance of local control to reduce local morbidity, however, should not be underestimated, and future research goals should include randomized clinical trials to further define the role of adjuvant irradiation alone or in combination with systemic therapy.

Original languageEnglish (US)
Pages (from-to)323-342
Number of pages20
JournalSurgical Clinics of North America
Volume83
Issue number2
DOIs
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

Melanoma
Adjuvant Radiotherapy
Radiotherapy
Hutchinson's Melanotic Freckle
Survival
Appointments and Schedules
Therapeutics
Randomized Controlled Trials
Prospective Studies
Radiation
Neoplasm Metastasis
Morbidity
Incidence

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Radiation therapy for malignant melanoma. / Ballo, Matthew; Ang, K. Kian.

In: Surgical Clinics of North America, Vol. 83, No. 2, 01.04.2003, p. 323-342.

Research output: Contribution to journalReview article

Ballo, Matthew ; Ang, K. Kian. / Radiation therapy for malignant melanoma. In: Surgical Clinics of North America. 2003 ; Vol. 83, No. 2. pp. 323-342.
@article{9ce986e48b244cd4ac24bef1177f76b4,
title = "Radiation therapy for malignant melanoma",
abstract = "Although surgery remains the primary treatment for patients with localized melanoma, available data indicate that there is a need for improved local-regional control in situations where complete surgical resection may be difficult or when high-risk features are noted pathologically. Retrospective and phase II prospective studies have revealed that elective/adjuvant radiotherapy can significantly improve the local-regional control rate in these clinical settings. The impact of elective/adjuvant radiotherapy on the incidence of distant metastasis and overall survival has yet to be determined, however. Additionally, there remains a role for radiotherapy as a primary treatment alternative for elderly patients with large facial lentigo maligna melanoma. The optimal radiation fractionation schedule remains controversial. The hypofactionated regimen is well tolerated, has resulted in improved local-regional control as compared with historical surgical results, and is convenient for a group of patients in whom survival expectations are low. Significant improvements in outcome will require commensurate improvements in systemic disease control. The importance of local control to reduce local morbidity, however, should not be underestimated, and future research goals should include randomized clinical trials to further define the role of adjuvant irradiation alone or in combination with systemic therapy.",
author = "Matthew Ballo and Ang, {K. Kian}",
year = "2003",
month = "4",
day = "1",
doi = "10.1016/S0039-6109(02)00096-8",
language = "English (US)",
volume = "83",
pages = "323--342",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Radiation therapy for malignant melanoma

AU - Ballo, Matthew

AU - Ang, K. Kian

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Although surgery remains the primary treatment for patients with localized melanoma, available data indicate that there is a need for improved local-regional control in situations where complete surgical resection may be difficult or when high-risk features are noted pathologically. Retrospective and phase II prospective studies have revealed that elective/adjuvant radiotherapy can significantly improve the local-regional control rate in these clinical settings. The impact of elective/adjuvant radiotherapy on the incidence of distant metastasis and overall survival has yet to be determined, however. Additionally, there remains a role for radiotherapy as a primary treatment alternative for elderly patients with large facial lentigo maligna melanoma. The optimal radiation fractionation schedule remains controversial. The hypofactionated regimen is well tolerated, has resulted in improved local-regional control as compared with historical surgical results, and is convenient for a group of patients in whom survival expectations are low. Significant improvements in outcome will require commensurate improvements in systemic disease control. The importance of local control to reduce local morbidity, however, should not be underestimated, and future research goals should include randomized clinical trials to further define the role of adjuvant irradiation alone or in combination with systemic therapy.

AB - Although surgery remains the primary treatment for patients with localized melanoma, available data indicate that there is a need for improved local-regional control in situations where complete surgical resection may be difficult or when high-risk features are noted pathologically. Retrospective and phase II prospective studies have revealed that elective/adjuvant radiotherapy can significantly improve the local-regional control rate in these clinical settings. The impact of elective/adjuvant radiotherapy on the incidence of distant metastasis and overall survival has yet to be determined, however. Additionally, there remains a role for radiotherapy as a primary treatment alternative for elderly patients with large facial lentigo maligna melanoma. The optimal radiation fractionation schedule remains controversial. The hypofactionated regimen is well tolerated, has resulted in improved local-regional control as compared with historical surgical results, and is convenient for a group of patients in whom survival expectations are low. Significant improvements in outcome will require commensurate improvements in systemic disease control. The importance of local control to reduce local morbidity, however, should not be underestimated, and future research goals should include randomized clinical trials to further define the role of adjuvant irradiation alone or in combination with systemic therapy.

UR - http://www.scopus.com/inward/record.url?scp=0037397144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037397144&partnerID=8YFLogxK

U2 - 10.1016/S0039-6109(02)00096-8

DO - 10.1016/S0039-6109(02)00096-8

M3 - Review article

VL - 83

SP - 323

EP - 342

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 2

ER -